112 related articles for article (PubMed ID: 22294321)
21. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
22. Two-dimensional electrophoresis for comparative proteomic analysis of human bile.
Chen B; Dong JQ; Chen YJ; Wang JM; Tian J; Wang CB; Zou SQ
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):402-6. PubMed ID: 17690038
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
[TBL] [Abstract][Full Text] [Related]
24. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
25. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
26. Differential expression proteomics of human colon cancer.
Mazzanti R; Solazzo M; Fantappié O; Elfering S; Pantaleo P; Bechi P; Cianchi F; Ettl A; Giulivi C
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1329-38. PubMed ID: 16439467
[TBL] [Abstract][Full Text] [Related]
27. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.
Tan Y; Ma SY; Wang FQ; Meng HP; Mei C; Liu A; Wu HR
Oncol Rep; 2011 Oct; 26(4):853-9. PubMed ID: 21687958
[TBL] [Abstract][Full Text] [Related]
28. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and predictive potential molecular biomarkers in colon cancer.
Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I
Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
31. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
32. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
33. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the human gastric fluid proteome reveals distinct pH-dependent protein profiles: implications for biomarker studies.
Kam SY; Hennessy T; Chua SC; Gan CS; Philp R; Hon KK; Lai L; Chan WH; Ong HS; Wong WK; Lim KH; Ling KL; Tan HS; Tan MM; Ho M; Kon OL
J Proteome Res; 2011 Oct; 10(10):4535-46. PubMed ID: 21842849
[TBL] [Abstract][Full Text] [Related]
35. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
36. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer.
Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; Páez de la Cadena M
Int J Biochem Cell Biol; 2007; 39(3):529-40. PubMed ID: 17084656
[TBL] [Abstract][Full Text] [Related]
37. Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma.
Melle C; Ernst G; Schimmel B; Bleul A; Mothes H; Kaufmann R; Settmacher U; Von Eggeling F
Int J Oncol; 2006 Jan; 28(1):195-200. PubMed ID: 16327996
[TBL] [Abstract][Full Text] [Related]
38. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
[TBL] [Abstract][Full Text] [Related]
39. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
Gromov P; Gromova I; Friis E; Timmermans-Wielenga V; Rank F; Simon R; Sauter G; Moreira JM
J Proteome Res; 2010 Aug; 9(8):3941-53. PubMed ID: 20527979
[TBL] [Abstract][Full Text] [Related]
40. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
